Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share
CTV.WS
CTV.WS was delisted on the 12th of February, 2025.
23 hedge funds and large institutions have $10.4M invested in Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
5% more funds holding
Funds holding: 22 → 23 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
73% less capital invested
Capital invested by funds: $38.9M → $10.4M (-$28.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LP
LMR Partners
London,
United Kingdom
|
+$508K |
| 2 |
HIIFS
Harel Insurance Investments & Financial Services
Ramat Gan,
Israel
|
+$66K |
| 3 |
LCG
Luxor Capital Group
New York
|
+$9.58K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$42 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BAMCO Inc
New York
|
-$344K |
| 2 |
SM
Senvest Management
New York
|
-$203K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$5.71K |
| 4 |
Neuberger Berman Group
New York
|
-$2.77K |
CTV.WS Hedge Fund Activity: Q2 2022 in Review
23 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share (CTV.WS) for Q2 2022, worth a combined $10.4M — down 73% from $38.9M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new CTV.WS positions and 2 closed out — a net gain of 1 holder — while 2 added to existing stakes and 3 trimmed.
The largest buyer was LMR Partners, adding an estimated $508K. The largest seller was BAMCO Inc, cutting an estimated $344K.
- 23 institutional investors held Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share (CTV.WS) as of Q2 2022, up from 22 in Q1 2022.
- Funds reported $10.4M of Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share stock for Q2 2022, down 73% quarter-over-quarter.
- 3 funds opened new Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share positions in Q2 2022 and 2 closed out, a net change of +1 holder.
- The largest Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share buyer in Q2 2022 was LMR Partners, an estimated $508K added.
- The largest Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share seller in Q2 2022 was BAMCO Inc, an estimated $344K sold.
Based on aggregated 13F filings for Q2 2022.